- Home
- XNCR vs CTOS Comparison
XNCR vs CTOS Comparison
Compare XNCR & CTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XNCR | CTOS |
|---|---|---|
| Founded | 1997 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 2013 | 2017 |
Fundamental Metrics
Financial Performance| Metric | XNCR | CTOS |
|---|---|---|
| Price | $24.77 | $9.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 6 |
| Target Price | ★ $31.42 | $13.33 |
| AVG Volume (30 Days) | ★ 1.0M | 698.1K |
| Earning Date | 11-04-2026 | 10-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.36 | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | $125,576,000.00 | ★ $1,943,957,000.00 |
| Revenue This Year | $14.05 | $9.25 |
| Revenue Next Year | N/A | $5.34 |
| P/E Ratio | ★ N/A | $307.33 |
| Revenue Growth | ★ 13.65 | 7.86 |
| 52 Week Low | $10.38 | $5.18 |
| 52 Week High | $30.61 | $12.23 |
Technical Indicators
Market Signals| Indicator | XNCR | CTOS |
|---|---|---|
| Relative Strength Index (RSI) | 51.52 | 40.62 |
| Support Level | $23.36 | $8.75 |
| Resistance Level | $30.61 | $9.58 |
| Average True Range (ATR) | 1.03 | 0.26 |
| MACD | -0.09 | 0.02 |
| Stochastic Oscillator | 55.23 | 27.06 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
About CTOS Custom Truck One Source Inc.
Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, forestry, telecom, waste management, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority revenue from the United States.